Bowman-Birk inhibitors in lentil: Heterologous expression, functional characterisation and anti-proliferative properties in human colon cancer cells

Food Chemistry

Volumn 120, Issue 4, 2010, Pages 1058-1066

  Caccialupi, Pasqua ^a   Ceci, Luigi R ^b   Siciliano, Rosa A ^b   Pignone, Domenico ^a   Clemente, Alfonso ^c   Sonnante, Gabriella ^a  

^a Institute of Biosciences and Bioresources   (Italy)

^b CNR   (Italy)

^c CSIC   (Spain)

Author keywords

Bowman Birk inhibitors; Cell proliferation; Colorectal cancer cells; Heterologous expression; Lentil; Pichia; Protease inhibitory activity

Indexed keywords

BOWMAN BIRK INHIBITOR; CHYMOTRYPSIN; COMPLEMENTARY DNA; TRYPSIN;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LENTIL; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS;

LENS CULINARIS; PICHIA; PICHIA PASTORIS;

EID: 74849134012     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2009.11.051     Document Type: Article

References (53)

1. Armstrong W.B., Kennedy A.R., Wan X.S., Taylor T.H., Nguyen Q.A., and Jensen J. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clinical Cancer Research 6 (2000) 4684-4691
2. Beekwilder J., Schipper B., Bakker P., Bosch D., and Jongsma M. Characterization of potato proteinase inhibitor II reactive site mutants. European Journal of Biochemistry 267 (2000) 1975-1984
3. Birk Y. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. International Journal of Peptide and Protein Research 25 (1985) 113-131
4. Bode W., and Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochimica et Biophysica Acta 1477 (2000) 241-252
5. Bronsoms S., Villanueva J., Canals F., Querol E., and Aviles F.X. Analysis of the effect of potato carboxypeptidase inhibitor prosequence on the folding of the mature protein. European Journal of Biochemistry 270 (2003) 3641-3650
6. Buchner J., Pastan I., and Brinkmann U. A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Analytical Biochemistry 205 (1992) 263-270
7. Chavan J.K., and Hejgaard J. Detection and partial characterization of subtilism inhibitors in legume seeds by isoelectric focusing. Journal of the Science of Food and Agriculture 32 (1981) 857-862
8. Chen Y.W., Huang S.C., Lin-Shiau S.Y., and Lin J.K. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26 (2005) 1296-1306
9. Clemente A., and Domoney C. Biological significance of polymorphism in plant protease inhibitors from the Bowman-Birk class. Current Protein and Peptide Science 7 (2006) 201-216
10. Clemente A., and Domoney C. Therapeutic properties of legume protease inhibitors from the Bowman-Birk class. In: N Govil J., Singh V.K., and Sharma R.K. (Eds). Recent progress in medicinal plants Vol. 20 (2007), SCI Tech Publishing LLC, Houston, USA 397-417
11. Clemente A., Gee J.M., Johnson I.T., Mackenzie D.A., and Domoney C. Protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro. Journal of Agriculture and Food Chemistry 53 (2005) 8979-8986
12. Clemente A., Jiménez E., Marín-Manzano M.C., and Rubio L.A. Functional Bowman-Birk inhibitors survive gastrointestinal digestion at the terminal ileum of cannulated pigs fed chickpea based diets. Journal of the Science of Food and Agriculture 88 (2008) 523-531
13. Clemente A., MacKenzie D.A., Jeenes D.J., and Domoney C. The effect of variation within inhibitory domains on the activity of pea protease inhibitors from the Bowman-Birk class. Protein Expression and Purification 36 (2004) 106-114
14. Clemente A., Vioque J., Sanchez-Vioque R., Pedroche J., Bautista J., and Millán F. Factors affecting the in vitro digestibility of chickpea albumins. Journal of the Science of Food and Agriculture 80 (2000) 79-84
15. Daly R., and Hearn M.T.W. Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production. Journal of Molecular Recognition 18 (2005) 119-138
16. De la Sierra I., Quillien L., Flecker P., Gueguen J., and Brunie S. Dimeric crystal structure of a Bowman-Birk protease inhibitor from pea seeds. Journal of Molecular Biology 285 (1999) 1195-1207
17. Domoney C. Inhibitors of legume seeds. In: Shewry P.R., and Casey R. (Eds). Seed proteins (1999), Kluwer Academic Publishers, Dordrecht, The Netherlands 635-655
18. Domoney C., Welham T., Sidebottom C., and Firmin J.L. Multiple isoforms of Pisum trypsin inhibitors result from modification of two primary gene products. FEBS Letters 360 (1995) 15-20
19. Fischer B., Sumner I., and Goodenough P. Isolation, renaturation and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnology and Bioengineering 41 (1993) 3-13
20. Gran B., Tabibzadeh N., Martin A., Ventura E.S., Ware J.H., Zhang G.X., et al. The protease inhibitor, Bowman-Birk inhibitor, suppresses experimental autoimmune encephalomyelitis: A potential oral therapy for multiple sclerosis. Multiple Sclerosis 12 (2006) 688-697
21. Jongsma M.A., Bakker P.L., and Stiekema W.J. Quantitative determination of serine proteinase inhibitor activity using a radial diffusion assay. Analytical Biochemistry 212 (1993) 79-84
22. Kennedy A.R. Chemopreventive agents: Protease inhibitors. Pharmacology & Therapeutics 78 (1998) 167-209
23. Kennedy A.R. The status of human trials utilizing Bowman-Birk inhibitor concentrate from soybeans. In: Sugano M. (Ed). Soy in health and disease prevention (2005), CRC Press LC
24. Kennedy A.R. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. American Journal of Clinical Nutrition 68 (2008) 1406S-1412S
25. Kennedy A.R., Billings P.C., Wan X.S., and Newberne P.M. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Nutrition and Cancer 43 (2002) 174-186
26. Kennedy A.R., and Wan X.S. Effects of the Bowman-Birk inhibitors on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells. The Prostate 50 (2002) 125-133
27. Lajolo F.M., and Genovese M.I. Nutritional significance of lectins and enzyme inhibitors from legume. Journal of Agriculture and Food Chemistry 50 (2002) 6592-6598
28. Laskowski M., and Kato I. Protein inhibitors of proteinases. Annual Revue of Biochemistry 49 (1980) 593-626
29. Lichtenstein G.R., Deren J., Katz S., Kennedy A.R., and Ware J.H. The Bowman-Birk protease inhibitor: a novel therapy for patients with active ulcerative colitis. Gastroenterology 122 (2002) A60
30. Liener I.E., and Kakade M.L. Protease inhibitors. In: Liener I.E. (Ed). Toxic constituents of plant foodstuffs (1980), Academic Press, New York 7-71
31. Lin J., Fido R., Shewry P., and Archer D.B. The expression and processing of two recombinant 2S albumins from soybean (Glycine max) in the yeast Pichia pastoris. Biochimica and Biophysica Acta 1698 (2004) 203-212
32. Livingstone D., Beilinson V., Kalyaeva M., Schmidt M.A., Herman M.E., and Nielsen N.C. Reduction of protease inhibitor activity by expression of a mutant Bowman-Birk gene in soybean seed. Plant Molecular Biology 64 (2007) 397-408
33. Losso J.N. The biochemical and functional food properties of the Bowman-Birk inhibitor. Critical Reviews in Food Science and Technology 48 (2008) 94-118
34. Maki P.A., Paterson Y., and Kennedy A.R. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans. Nutrition and Cancer 22 (1994) 185-193
35. Malkowicz S.B., McKenna W.G., Vaughn D.J., Wan X.S., Propert K.J., Rockwell K., et al. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate 48 (2001) 16-28
36. Marín-Manzano M.C., Ruiz R., Jimenez E., Rubio L.A., and Clemente A. Anti-carcinogenic Bowman-Birk inhibitors from soybean survive fermentation in active form using faecal inoculum and do not affect the microbiota composition. The British Journal of Nutrition 101 (2009) 967-971
37. Ragg E.M., Galbusera V., Scarafoni A., Negri A., Tedeschi G., Consonni A., et al. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris L.) seeds. FEBS Journal 273 (2006) 4024-4039
38. Ramasarma P.R., Appu Rao A.G., and Rao D.R. Role of disulfide linkages in structure and activity of proteinase inhibitor from Dolichos biflorus. Biochimica et Biophysica Acta 1248 (1995) 35-42
39. Richardson M. Seed storage proteins: The enzyme inhibitors. Methods in Plant Biochemistry 5 (1991) 259-305
40. Ryan C.A. Protease inhibitors in plants: Genes for improving defences against insects and pathogens. Annual Review of Phytopathology 28 (1990) 425-449
41. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press
42. Scarafoni A., Consonni A., Galbusera V., Negri A., Tedeschi G., Rasmussen P., et al. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds. Phytochemistry 69 (2008) 1820-1825
43. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochemical and Biophysical Research Communications 27 (1967) 157-162
44. Shewry P.R. Enzyme inhibitor of seeds: Types and properties. In: Shewry P.R., and Casey R. (Eds). Seed proteins (1999), Kluwer Academic Publishers, Dordrecht, The Netherlands 587-615
45. Sonnante G., De Paolis A., and Pignone D. Bowman-Birk inhibitors in Lens: Identification and characterization of two paralogous gene classes in cultivated lentil and wild relatives. Theoretical and Applied Genetics 110 (2005) 596-604
46. Sonnante G., Hammer K., and Pignone D. From the cradle of agriculture a handful of lentils: History of a domestication. Rendiconti Lincei 20 (2009) 21-37
47. Srinivasan A., Giri A.P., Harsulkar A.M., Gatehouse J.A., and Gupta V.S. A Kunitz trypsin inhibitor from chickpea (Cicer arietinum L.) that exerts anti-metabolic effect on podborer (Helicoverpa armigera) larvae. Plant Molecular Biology 57 (2005) 359-374
48. Volpicella M., Ceci L.R., Cordewener J., America T., Gallerani R., Brode W., et al. Properties of purified gut trypsin from Helicoverpa zea, adapted to proteinase inhibitors. European Journal of Biochemistry 270 (2003) 10-19
49. Volpicella M., Schipper A., Jongsma M.A., Spoto N., Gallerani R., and Ceci L.R. Characterization of recombinant mustard trypsin inhibitor 2 (MTI2) expressed in Pichia pastoris. FEBS Letters 468 (2000) 137-141
50. Ware J.H., Wan X.S., Newberne P., and Kennedy A.R. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Digestive Diseases Sciences 44 (1999) 986-990
51. Weder J.K.P., and Hinkers S.C. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors. Journal of Agriculture and Food Chemistry 52 (2004) 4219-4226
52. Weder J.K.P., and Kahleyss R. Isolation and characterisation of four trypsin-chymotrypsin inhibitors from lentil seeds. Journal of the Science of Food and Agriculture 78 (1998) 429-434
53. Weder J.K.P., and Kahleyss R. Reaction of lentil trypsin-chymotrypsin inhibitors with human and bovine proteinases. Journal of Agriculture and Food Chemistry 51 (2003) 8045-8050